Anesthetic Considerations for Patients Taking Glucagon

Anesthetic Considerations for Patients Taking Glucagon Like Peptide 1
Anesthetic Considerations for Patients Taking Glucagon Like Peptide 1

Semaglutide, more commonly known by the brand names Ozempic®, Rybelsus®, and Wegovy™ is a glucagon-like peptide-1 (GLP-1) agonist that has been used for several years in the management of type 2 diabetes mellitus (T2DM).

From a Glycocentric Approach to Prevention of Multi Organ Damage
From a Glycocentric Approach to Prevention of Multi Organ Damage

This review is intended to rationally compile the multifactorial cardiovascular effects of glucagon-like peptide-1 receptor agonists available for the treatment of patients with type 2 diabetes.

Anesthetic Considerations in Adult Patients on Glucagon

Risk of major adverse cardiovascular events and stroke associated
Risk of major adverse cardiovascular events and stroke associated

Anesthetic Considerations in Adult Patients on Glucagon-Like Peptide-1 Receptor Agonists: Gastrointestinal Focus Joshi, Girish P. MBBS, MD, FFARCSI Author Information

Patients taking glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic peptide receptor agonists should: continue these drugs before surgery; have full risk assessment and stratification; and receive peri-operative techniques that may mitigate risk of pulmonary aspiration before, during and after sedation or general ...

Glp 1 Agonist Conversion Chart RUWKHS
Glp 1 Agonist Conversion Chart RUWKHS

Perioperative management of patients taking glucagon

The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients . This document represents a multidisciplinary consensus statement led by the Society ...

Summary The perioperative management of patients using glucagon-like peptide 1 receptor agonists remains a topic of debate. While several multisociety statements have been published recently, the recommendations vary significantly in terms of medication management and preoperative fasting protocols for these patients .

GLP 1 agonists Archives NSF News
GLP 1 agonists Archives NSF News

Perioperative management of patients taking glucagon

Authors: Oprea AD et al. British Journal of Anaesthesia, volume 135, issue 1 , 2026 This multidisciplinary consensus statement from the Society for Perioperative Assessment and Quality Improvement (SPAQI) addresses the increasingly common perioperative challenge of managing patients taking glucagon-like peptide-1 receptor agonists (GLP-1 RAs). With widespread use for diabetes mellitus, obesity ...

Most patients should continue taking their glucagon-like peptide-1 (GLP-1) receptor agonists before elective surgery, suggests new clinical guidance released by the American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of ...

New Developments in Pharmacological Treatment of Obesity and Type 2
New Developments in Pharmacological Treatment of Obesity and Type 2

American Society of Anesthesiologists Consensus

American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Update: In October 2024, ASA issued an Affirmation of Value for a more recent, multi-society guidance GLP-1 document. Read more ...

New GLP 1 Guidelines for Type 2 Diabetes in 2025
New GLP 1 Guidelines for Type 2 Diabetes in 2025
How do GLP 1 Agonists Work EASY Pharmacology
How do GLP 1 Agonists Work EASY Pharmacology
10 Cardiovascular Disease and Risk Management Standards of Care
10 Cardiovascular Disease and Risk Management Standards of Care
Answer to an FAQ Do Injectable Weight Loss Drugs GLP 1 Agonists
Answer to an FAQ Do Injectable Weight Loss Drugs GLP 1 Agonists

Glucagon-like peptide-1 (GLP-1) agonists are very popular and useful medications for the treatment of type 2 diabetes mellitus and obesity. Potent gastric emptying delay is common with these medications, serving as a major contributor to the ...